Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning

…, E Domingo, SD Richman, KL Redmond… - Gut, 2021 - gut.bmj.com
Objective Complex phenotypes captured on histological slides represent the biological
processes at play in individual cancers, but the link to underlying molecular classification has not …

EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer

…, S Dasgupta, JK Blayney, DG McArt, KL Redmond… - Clinical Cancer …, 2016 - AACR
Purpose: EphA2, a member of the Eph receptor tyrosine kinases family, is an important
regulator of tumor initiation, neovascularization, and metastasis in a wide range of epithelial and …

[HTML][HTML] ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer

…, R Carson, W Allen, PV Jithesh, KL Redmond… - Cell reports, 2014 - cell.com
There are currently no approved targeted therapies for advanced KRAS mutant (KRASMT)
colorectal cancer (CRC). Using a unique systems biology approach, we identified JAK1/2-…

Biological misinterpretation of transcriptional signatures in tumor samples can unknowingly undermine mechanistic understanding and faithful alignment with …

…, R Amirkhah, AJ McCooey, E Rogan, KL Redmond… - Clinical Cancer …, 2022 - AACR
Purpose: Precise mechanism-based gene expression signatures (GES) have been
developed in appropriate in vitro and in vivo model systems, to identify important cancer-related …

[HTML][HTML] Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

…, E Grassi, M Viviani, E Rogan, KL Redmond… - Nature Genetics, 2024 - nature.com
Molecular stratification using gene-level transcriptional data has identified subtypes with
distinctive genotypic and phenotypic traits, as exemplified by the consensus molecular subtypes …

In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer

…, E Domingo, A Blake, S Hassanieh, KL Redmond… - Clinical Cancer …, 2021 - AACR
Purpose: The DNA damage immune response (DDIR) assay was developed in breast cancer
based on biology associated with deficiencies in homologous recombination and Fanconi …

Overcoming resistance to targeted therapies in cancer

KL Redmond, A Papafili, M Lawler… - Seminars in …, 2015 - Elsevier
The recent discovery of oncogenic drivers and subsequent development of novel targeted
strategies has significantly added to the therapeutic armamentarium of anti-cancer therapies. …

[HTML][HTML] Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features

…, D Strathdee, L Bartholin, KL Redmond… - Nature …, 2022 - nature.com
The pro-tumourigenic role of epithelial TGFβ signalling in colorectal cancer (CRC) is
controversial. Here, we identify a cohort of born to be bad early-stage (T1) colorectal tumours, with …

[HTML][HTML] Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt

LR Dutton, OP Hoare, AMB McCorry, KL Redmond… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Gremlin1 (GREM1) is a secreted glycoprotein member of the differential screening-selected
gene in aberrant neuroblastoma (DAN) family of bone morphogenetic protein (BMP) …

Activation of innate-adaptive immune machinery by poly (I: C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer

…, X Cortes-Lavaud, R Amirkhah, KL Redmond… - Gut, 2022 - gut.bmj.com
Objective Stroma-rich tumours represent a poor prognostic subtype in stage II/III colon cancer
(CC), with high relapse rates and limited response to standard adjuvant chemotherapy. …